![Alex Zhavoronkov, founder and CEO of Insilico Medicine, a clinical stage biotech company powered by generative AI. Photo: Insilico Medicine](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/HDQ5NRCWSBC5PA6QK2UVIPYXEY.jpg?smart=true&auth=8191625bb3f0d9a41ca7fa233bc8853835b0491d2fdb5c472001ca3762554ae0&width=400&height=225)
Alex Zhavoronkov, founder and CEO of Insilico Medicine, a clinical stage biotech company powered by generative AI. Photo: Insilico Medicine
Alex Zhavoronkov, founder and CEO of Insilico Medicine, a clinical stage biotech company powered by generative AI. Photo: Insilico Medicine
AI-generated drugs can lead new era in fight against disease, biotech chief says
It is hoped that life-saving drugs will be more effective and cheaper to produce